Zelluna ASA

kr 16.50As of Sun 8 Nov 2026, 12:00 UTC
OSL:ZLNAHealthcare
Country Norway
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (139.82%)
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM 50.00%
Mkt cap kr 492.7M
ROIC (84.88%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 17
0.78%
(93.65%)
Hold 6|12|2|12|8
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.32
0.36
0.40
0.43
17.32%
28.48%
37.89%
48.07%
Revenuekr M
21.39
21.41
21.71
21.84
2.56%
2.22%
0.19%
2.98%
Peers (US$52.12M)
Cap (US$)
PE
40.58M
—
Capital
TTM
5Y
10Y
Leveragex
0.947
(0.526)
(0.447)
EBIT/Intx
0.787
0.951
0.934
Own earn%
134.90
118.87
104.15
Sh yield%
19.95
45.44
44.87
Owners
Insiders/Inst%
4.72
46.33
Short interest%
5.20
SBC / revenue%
1.27
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
3–7
$1 testx
—
Incr. ROIC%
10